ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Alligator Bioscience signs antibody agreement for Greater China
August 22, 2019Alligator has granted Biotheus rights in Greater China to an antibody from ALLIGATOR-GOLD® for the creation of up to three bispecific molecules. -
Alligator Bioscience regains cancer asset rights from Janssen
August 01, 2019Swedish biotech firm Alligator Bioscience has regained the global rights for tumour-directed immunotherapy ADC-1013 (JNJ-64457107) from Janssen Biotech. -
Aptevo, Alligator in Bispecific Antibody Development Pact
July 24, 2017Aptevo Therapeutics Inc. and Alligator Bioscience have entered into an agreement to co-develop an immunotherapy bispecific antibody candidate, ALG.APV-527, based on Alligator’s first generation bispecific antibody, ATOR-1016.
Pharma Sources Insight January 2025
